Search Within

Roni Shouval

Formats
  1. Meeting Abstract (92)
  2. Journal Article (63)
  3. Review (6)
  4. Editorial (4)
  5. Research Letter (4)
  6. Correspondence (2)
  7. Book Section (1)
  8. Guidelines (1)
Groups
  1. Hematologic Malignancies, Division of (173)
  2. Center for Hematologic Malignancies (112)
  3. Department of Medicine (112)
  4. Bone Marrow Transplant (105)
  5. CTCR Scholars (88)
  6. Survivorship Research (86)

More Groups

People
  1. Miguel-Angel Perales (101)
  2. Michael Scordo (83)
  3. Gunjan Shah (80)
  4. Maria Palomba (75)
  5. Sean Devlin (65)
  6. Parastoo Dahi (64)

More People

Years
  1. 2025 (22)
  2. 2024 (42)
  3. 2023 (49)
  4. 2022 (23)
  5. 2021 (16)
  6. 2020 (15)

More Years

Publications
  1. Blood (65)
  2. Bone Marrow Transplantation (20)
  3. Blood Advances (14)
  4. Transplantation and Cellular Therapy (13)
  5. Biology of Blood and Marrow Transplantation (6)
  6. Hematological Oncology (5)

More Publications

Publishers
  1. American Society of Hematology (80)
  2. Elsevier Inc. (27)
  3. Nature Publishing Group (27)
  4. Wiley Blackwell (5)
  5. American Association for Cancer Research (4)
  6. Ferrata Storti Foundation (4)

More Publishers

Results (173)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Point-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B-cell lymphoma
    Journal Article

    Kedmi, M.; Shouval, R.; Fried, S.; Bomze, D.; Fein, J.; Cohen, Z.; Danilesko, I.; Shem-Tov, N.; Yerushalmi, R.; Jacoby, E.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant
    Journal Article

    Miltiadous, O.; Waters, N. R.; Andrlová, H.; Dai, A.; Nguyen, C. L.; Burgos da Silva, M.; Lindner, S.; Slingerland, J.; Giardina, P.; Clurman, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • The Simplified Comorbidity Index: A new tool for prediction of nonrelapse mortality in allo-HCT
    Journal Article

    Shouval, R.; Fein, J. A.; Cho, C.; Avecilla, S. T.; Ruiz, J.; Alarcon Tomas, A.; Sanchez-Escamilla, M.; Castillo Flores, N.; Yáñez, L.; Barker, J. N.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Machine learning-based prediction of 1-year mortality for acute coronary syndrome
    Journal Article

    Hadanny, A.; Shouval, R.; Wu, J.; Gale, C. P.; Unger, R.; Zahger, D.; Gottlieb, S.; Matetzky, S.; Goldenberg, I.; Beigel, R.; more...
    Journal of Cardiology (2022)

    Fulltext@MSK | Save
  • Impact of TP53 genomic alterations in large B-cell lymphoma treated with CD19-chimeric antigen receptor T-cell therapy
    Journal Article

    Shouval, R.; Alarcon Tomas, A.; Fein, J. A.; Flynn, J. R.; Markovits, E.; Mayer, S.; Afuye, A. O.; Alperovich, A.; Anagnostou, T.; Besser, M. J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Origins of bloodstream infections following fecal microbiota transplantation: A strain-level analysis
    Journal Article

    Eshel, A.; Sharon, I.; Nagler, A.; Bomze, D.; Danylesko, I.; Fein, J. A.; Geva, M.; Henig, I.; Shimoni, A.; Zuckerman, T.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Novel agents may be preferable to chemotherapy for large B-cell lymphoma progressing after CD19-CAR-T: A multicenter observational study
    Meeting Abstract

    Tomas, A. A.; Fein, J. A.; Fried, S.; Fingrut, W.; Anagnostou, T.; Alperovich, A.; Shah, N.; Fraint, E.; Lin, R. J.; Scordo, M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Silverman, E. A.; Hubbeling, H.; Palomba, M. L.; Wijetunga, N. A.; Tringale, K.; Lebow, E.; Tomas, A. A.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Lesion characteristics and patterns of failure in diffuse large B cell lymphoma patients treated with bridging radiotherapy prior to chimeric antigen receptor T cell therapy
    Meeting Abstract

    Hubbeling, H.; Silverman, E. A.; Wijetunga, N. A.; Palomba, M. L.; Tringale, K.; Lebow, E.; Tomas, A. A.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Encouraging survival and high rates of toxicity: Allogeneic hematopoietic cell transplantation after anti-CD19 chimeric antigen receptor T-cell therapy in aggressive lymphoma patients
    Meeting Abstract

    Fried, S.; Danylesko, I.; Yerushalmi, R.; NogaShem, Tov; Shouval, R.; Fein, J. A.; Cohen, Z.; Jacoby, E.; Besser, M.; Nagler, A.; more...
    Blood (2021)

    Fulltext@MSK | Save